Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Hongmei Zeng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3999-3081; OpenAlex author ID A5004337669. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 3

  1. A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. First author DOI 10.3390/cancers13112565↗
  2. Pancreatic cancer incidence and mortality patterns in China, 2011. Co-author DOI 10.3978/j.issn.1000-9604.2015.02.05↗
  3. Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e31821268d1↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lingeng Lu · 2 shared papers, 2011–2021 · strength 0.17
  2. Béatrice Fervers · 1 shared paper, 2021 · strength 0.15
  3. Yixing Wu · 1 shared paper, 2021 · strength 0.15
  4. Yufang He · 1 shared paper, 2015 · strength 0.06
  5. Wanqing Chen · 1 shared paper, 2015 · strength 0.06
  6. Mark S. Kidd · 1 shared paper, 2011 · strength 0.03
  7. Herbert Yu · 1 shared paper, 2011 · strength 0.03
  8. Muhammad Wasif Saif · 1 shared paper, 2011 · strength 0.03
  9. Harvey A. Risch Risch · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.